2 great FTSE 100 stocks to own heading into a recession

Jabran Khan identifies two FTSE 100 stocks he feels are recession-proof and details their defensive capabilities.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Young brown woman delighted with what she sees on her screen

Image source: Getty Images

Many believe that a recession could be on the cards. With that in mind, I am on the lookout for the best FTSE 100 stocks for my holdings.

I have identified two I believe could be great picks. Let’s take a closer look at them.

Healthcare

My first pick is GlaxoSmithKline (LSE:GSK). It is one of the world’s biggest healthcare businesses developing and selling medicines and vaccines with a global footprint.

Healthcare stocks are often seen as recession-proof due to their defensive and essential nature. No matter the state of the economy, people need healthcare and medicines. Furthermore, the pandemic shone a new light on the importance of health and well-being in the past couple of years.

So what’s happening with GlaxoSmithKline shares currently? They’re trading for 1,786p, as I write. At this time last year, the shares were trading for 1,419p, which is a 25% increase over a 12-month period.

Although arguably recession-proof, Glaxo stock does have risks. Current macroeconomic headwinds such as the rising cost of materials and the supply chain crisis could negatively impact operations, performance and returns. These issues are affecting many FTSE 100 stocks, however

As well as GlaxoSmithKline’s defensive capabilities, it has a good track record of performance in recent years. I do understand that past performance is not a guarantee of the future, however. Positive performance and profits leads to investor returns in the form of dividends that could boost my passive income stream. Glaxo’s current dividend yield is 4.3%, higher than the FTSE 100 average of 3%-4%.

I would add GlaxoSmithKline shares to my holdings heading into a recession. Its profile, presence, performance record, as well as the passive income opportunity are too good to miss. It also has an excellent pipeline of drugs, which should support future growth.

Utilities

My next pick is National Grid (LSE:NG). It is the UK’s electricity system operator providing the population with power. In addition to this, in the US it powers 20m customers across Massachusetts, New York and Rhode Island.

Like healthcare, utilities are also often seen as defensive stocks in times of economic uncertainty. Power is one of the modern-day essentials for our homes and businesses after all.

So what’s happening with the National Grid share price currently? Well, as I write, they are trading for 1,080p. At this time last year, the stock was trading for 920p, which is a 17% increase over a 12-month period.

National Grid shares have risks, too. I did notice that it has a significant amount of debt on its balance sheet. Due to rising interest rates, this debt could become costlier to service. In turn, this could affect investor returns and sentiment.

The firm also has a good record of performance. This performance underpins a healthy dividend yield of close to 5%. Utility stocks are often seen as passive income safe-havens. It is worth noting, though, dividends can be cancelled at the discretion of the business at any time. This tends to happen more so during difficult economic periods or extreme events such as a pandemic.

I would happily add National Grid shares to my holdings, and view them as a defensive option for my portfolio for any impending recession.

Jabran Khan has no position in any shares mentioned. The Motley Fool UK has recommended GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

ISA coins
Dividend Shares

4 UK shares that could provide a 10%+ annual ISA return

Jon Smith points out several stocks that could be included in a diversified ISA portfolio to help generate a yield…

Read more »

British pound data
Investing Articles

3 shares to consider buying as the FTSE 100 plummets

For those with cash on the sidelines and a long-term horizon, an equity market slump is less of a crisis…

Read more »

Calendar showing the date of 5th April on desk in a house
Investing Articles

2 FTSE 100 blue-chips to consider for a Stocks and Shares ISA before 5 April

Looking for ideas for a Stocks and Shares ISA before the forthcoming allowance deadline? Ben McPoland highlights two FTSE 100…

Read more »

Storytelling image of a multiethnic senior couple in love - Elderly married couple dating outdoors, love emotions and feelings
Investing Articles

How much will you need in a SIPP to earn a £3k monthly passive income in 2053?

A SIPP can be an exceptional wealth-building tool. Royston Wild explains how -- and reveals a top FTSE 100 dividend…

Read more »

Happy retired couple on a yacht
Investing Articles

3 easy steps to target a £1,000,000 Stocks and Shares ISA!

Looking to get a seat on millionaire's row? Royston Wild reveals three top strategies that could supercharge your Stocks and…

Read more »

Calendar showing the date of 5th April on desk in a house
Investing Articles

3 things to do right now as the annual ISA deadline looms!

With the ISA contribution deadline less than three weeks away, our writer runs through a trio of things he has…

Read more »

piggy bank, searching with binoculars
Growth Shares

It could be a once-in-a-decade opportunity to buy this cheap FTSE 250 stock

Jon Smith points out a FTSE 250 stock he's weighing up as to whether it could be a rare opportunity…

Read more »

Close-up image depicting a woman in her 70s taking British bank notes from her colourful leather wallet.
Investing Articles

At over 10%, I couldn’t resist this FTSE 250 share’s yield!

Christopher Ruane explains why he has bought into a 10%+ yielding FTSE 250 income share that the market has lately…

Read more »